Skip to main content

Table 1 Demographic and clinical characteristics of patients (n = 382)

From: Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study

Variable N (%) or Mean ± SD
Age, years (mean ± SD) 40 ± 10.9
Gender (male) 89 (23.3%)
Marital status
 Single 154 (40.3%)
 Married 228 (59.7%)
level of education
 Undergraduate 27(7.1%)
 Diploma 102(26.7%)
 Associate degree 15(3.9%)
 Bachelor 152(39.8%)
 Master 64(16.8%)
 Professional doctoral degree 22(5.8%)
Job
 Unemployed 28 (7.3%)
 Freelance 134 (35.1%)
 Government 16 (4.2%)
 Housewife 168 (44%)
 Student 13 (3.4%)
 Retired 23 (6%)
Income
 No income 214 (56%)
 1–5 million toman/month 81 (21.2%)
 5–10 million toman/month 62 (16.2%)
  > 10 million toman/month 25 (6.5%)
Physical activity
 Low 246 (64.4%)
 Moderate 88 (23%)
 High 48 (12.6%)
Comorbidity
 Heart disease 6 (1.6%)
 Diabetes 7 (1.8%)
 Hypertension 15 (3.9%)
 Hypothyroid 20 (5.2%)
Hyperthyroid 2 (0.5%)
 Cancer 6 (1.6%)
 Stroke 1 (0.3%)
 Depression 19 (5%)
Duration of MS* disease, months 111 ± 78
MS subtype
 RRMS* 354 (92.7%)
 PMS* 28 (7.3%)
Mode of MS medication administration
 Oral 254 (66.5%)
 Injection 128 (33.5%)
Anti-depressant drugs
 Tricyclic antidepressants 1%
 Selective serotonin reuptake inhibitors 1.7%
 Serotonin-norepinephrine reuptake inhibitor 1.5%
 Atypical 0.5%
Antianxiety drugs
 anticonvulsant 2.4%
 benzodiazepines 1.3%
 Nonbenzodiazepines 0.5%
Supplements
 Yes 305 (79.8%)
 No 77 (20.2%)
 Number of daily supplements used 1 ± 1.3
 Supplement used duration, months 79.2 ± 105
  1. MS Multiple sclerosis, RRMS relapsing-remitting Multiple sclerosis, PMS Progressive multiple sclerosis